Completed NA INTERVENTIONAL NCT00358839

Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2.

Sponsor: Danish Headache Center

Interventions CGRP

Updated 5 times since 2017 Last updated: Nov 9, 2006 Started: Jul 31, 2006 Completion: Oct 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Familial Hemiplegic Migraine and is currently completed. Danish Headache Center leads this study, which shows 5 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jul 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Danish Headache Center
EUROHEAD

Data source: Danish Headache Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Glostrup, Copenhagen, Denmark